We are live on ! Find out more
JSPRW icon

Japer Therapeutics Warrants
JSPRW

35 hedge funds and large institutions have $4.99M invested in Japer Therapeutics Warrants in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 12 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

10% more capital invested

Capital invested by funds: $4.51M → $4.99M (+$473K)

0% more funds holding

Funds holding: 35 → 35 (0)

83% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 12

Holders
35
Holders Change
–
Holders Change %
0%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
12
Closed
2
Calls
$292K
Puts
–
Net Calls
+$292K
Net Calls Change
+$292K

Top Buyers

Rank Fund Capital Flow
1
OAC
OMERS Administration Corp
Ontario, Canada
+$53.3K
2
GCL
Glazer Capital LLC
New York
+$46.6K
3
ES
Equitec Specialists
Illinois
+$36.6K
4
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
+$5.27K

Top Sellers

Rank Fund Capital Flow
1
SRCM
Sage Rock Capital Management
New York
-$404K
2
AIMCA
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
-$53.9K
3
BCM
Basso Capital Management
Connecticut
-$51.3K
4
PC
Periscope Capital
Ontario, Canada
-$48K
5
Verition Fund Management
Verition Fund Management
Connecticut
-$47.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
OCAM
1
Owl Creek Asset Management
New York
$974K -$10.6K -8,443 -1%
TCM
2
Tenor Capital Management
New York
$363K – – –
PSAMP
3
P. Schoenfeld Asset Management (PSAM)
New York
$344K – – –
SRCM
4
Sage Rock Capital Management
New York
$277K -$404K -322,000 -63%
AA
5
AQR Arbitrage
Connecticut
$272K – – –
PMAM
6
Picton Mahoney Asset Management
Ontario, Canada
$272K – – –
BFM
7
Boothbay Fund Management
New York
$246K – – –
GCL
8
Glazer Capital LLC
New York
$242K +$46.6K +37,144 +29%
PAMP
9
Polar Asset Management Partners
Ontario, Canada
$236K – – –
ACM
10
Altium Capital Management
New York
$236K +$204K +162,500 New
BCM
11
Beryl Capital Management
California
$183K – – –
MS
12
Maven Securities
Jersey
$155K – – –
BI
13
Bulldog Investors
New Jersey
$131K -$2.63K -2,100 -2%
MIM
14
Monashee Investment Management
Massachusetts
$127K – – –
LIM
15
Longfellow Investment Management
Massachusetts
$112K – – –
LA
16
Linden Advisors
New York
$97K – – –
RCM
17
Rivernorth Capital Management
Florida
$95K -$38.9K -31,003 -32%
Verition Fund Management
18
Verition Fund Management
Connecticut
$81K -$47.8K -38,112 -40%
AGM
19
Alpine Global Management
New York
$74K – – –
OAC
20
OMERS Administration Corp
Ontario, Canada
$62K +$53.3K +42,500 New
YCM
21
Yakira Capital Management
Connecticut
$60K – – –
HF
22
HRT Financial
New York
$58K – – –
AIMCA
23
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$54K -$53.9K -43,000 -54%
ES
24
Equitec Specialists
Illinois
$42K +$36.6K +29,201 New
CAPTRUST Financial Advisors
25
CAPTRUST Financial Advisors
North Carolina
$38K +$5.27K +4,200 +19%
1
2

JSPRW Hedge Fund Activity: Q4 2020 in Review

35 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Japer Therapeutics Warrants (JSPRW) for Q4 2020, worth a combined $4.99M — up 10% from $4.51M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new JSPRW positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 12 trimmed.

The largest buyer was OMERS Administration Corp, opening a new position worth an estimated $53.3K. The largest seller was Sage Rock Capital Management, cutting an estimated $404K.

  • 35 institutional investors held Japer Therapeutics Warrants (JSPRW) as of Q4 2020, unchanged from Q3 2020.
  • Funds reported $4.99M of Japer Therapeutics Warrants stock for Q4 2020, up 10% quarter-over-quarter.
  • 3 funds opened new Japer Therapeutics Warrants positions in Q4 2020 and 2 closed out, a net change of +1 holder.
  • The largest Japer Therapeutics Warrants buyer in Q4 2020 was OMERS Administration Corp, an estimated $53.3K added.
  • The largest Japer Therapeutics Warrants seller in Q4 2020 was Sage Rock Capital Management, an estimated $404K sold.

Based on aggregated 13F filings for Q4 2020.